General
Preferred name
ELACRIDAR
Synonyms
GG918 ()
GW0918 ()
GW120918 ()
GF120918 ()
ELACRIDAR HYDROCHLORIDE ()
GF120918A ()
Elacridar (hydrochloride) ()
Elacridar (GF120918) ()
GW120918, GG918, GW0918 ()
LY-335979 ()
LY335979 ()
GF 120918A ()
Elacridar hcl ()
GF-120918A ()
P&D ID
PD008694
CAS
143664-11-3
143851-98-3
178436-75-4
Tags
available
drug candidate
Drug indication
Antineoplastic (adjunct)
Solid tumour/cancer
Drug Status
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Potent and selective KCC2 inhibitor (Tocris Bioactive Compound Library)
Cell lines
2
Organisms
0
Compound Sets
14
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
50
Properties
(calculated by RDKit )
Molecular Weight
563.24
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
6
Aromatic Ring Count
5
cLogP
5.56
TPSA
92.89
Fraction CSP3
0.24
Chiral centers
0.0
Largest ring
6.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Neuroscience
Target
P-gp?(P-glycoprotein)
ABCB1
P-gp inhibitor
BCRP
P-glycoprotein
P-gp
Primary Target
Multidrug Transporters
MOA
Inhibitor
P glycoprotein inhibitor
Source data